Funding

Osanni Bio

United States · Biotech · Healthtech · Enterprise software

Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model

Visit osanni.bioFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$190MHorowitz Group — Role not disclosedInvus Opportunities — Role not disclosedPatient Square Capital — Role not disclosedRetinal Degeneration Fund — Role not disclosed

Investors

Horowitz GroupSeries BInvus OpportunitiesSeries BPatient Square CapitalSeries BRetinal Degeneration FundSeries B

Coverage

Jun 23, 2026Osanni Bio · Series B

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Sourcesosanni.bio ↗